Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of iBio Inc (NASDAQ: IBIO) closed at $0.76 in the last session, up 3.41% from day before closing price of $0.74. In other words, the price has increased by $3.41 from its previous closing price. On the day, 0.68 million shares were traded. IBIO stock price reached its highest trading level at $0.78 during the session, while it also had its lowest trading level at $0.74.
Ratios:
We take a closer look at IBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On November 29, 2021, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $1.50.
On January 22, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on January 22, 2021, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 10 ’25 when Duran Felipe bought 9,191 shares for $2.72 per share. The transaction valued at 25,000 led to the insider holds 11,139 shares of the business.
Brenner Martin bought 9,191 shares of IBIO for $25,000 on Jan 10 ’25. The insider now owns 18,316 shares after completing the transaction at $2.72 per share. On Jan 10 ’25, another insider, Banjak Marc, who serves as the Chief Legal Officer of the company, bought 9,191 shares for $2.72 each. As a result, the insider paid 25,000 and bolstered with 11,066 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IBIO now has a Market Capitalization of 12338021 and an Enterprise Value of 11927217. For the stock, the TTM Price-to-Sale (P/S) ratio is 32.47 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at 31.806 whereas that against EBITDA is -0.744.
Stock Price History:
The Beta on a monthly basis for IBIO is 0.61, which has changed by -0.6576576 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, IBIO has reached a high of $6.89, while it has fallen to a 52-week low of $0.64. The 50-Day Moving Average of the stock is -5.79%, while the 200-Day Moving Average is calculated to be -67.81%.
Shares Statistics:
According to the various share statistics, IBIO traded on average about 2.52M shares per day over the past 3-months and 552770 shares per day over the past 10 days. A total of 16.22M shares are outstanding, with a floating share count of 15.30M. Insiders hold about 5.67% of the company’s shares, while institutions hold 15.95% stake in the company. Shares short for IBIO as of 1751241600 were 2250783 with a Short Ratio of 0.89, compared to 1748563200 on 633804. Therefore, it implies a Short% of Shares Outstanding of 2250783 and a Short% of Float of 13.889999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
